Skip to main content

Table 4 Patient treatment characteristics and laboratory data as reported in CROWNWeb, by recovery status

From: Predictors of kidney function recovery among incident ESRD patients

Variablea

All

Patients With Recovery (n = 16,930)

Patients Without Recovery (n = 355,457)

P-value

N

Mean (SD) or Proportion

N

Mean (SD) or Proportion

N

Mean (SD) or Proportion

Albumin (g/dL)

353,182

3.5 (0.5)

16,012

3.4 (0.5)

337,170

3.5 (0.5)

< 0.001

Calcium (mg/dL)

355,196

8.8 (0.6)

16,226

8.9 (0.6)

338,970

8.8 (0.6)

< 0.001

Hemoglobin (g/dL)

357,569

10.4 (1.0)

16,365

10.3 (1.2)

341,204

10.4 (1.0)

< 0.001

ESA monthly dose (units)

299,143

43,949 (40196)

12,284

39,733 (40193)

286,859

44,130 (40187)

< 0.001

Ferritin

342,910

460 (328)

15,232

533 (373)

327,678

458 (325)

< 0.001

Iron % saturation

349,400

24.1 (8.8)

15,769

23 (10.1)

333,631

24.1 (8.8)

< 0.001

IV Iron administration

 Yes

212,999

59.7%

8534

52.7%

204,465

60.0%

< 0.001

 No

144,016

40.3%

7647

47.3%

136,369

40.0%

 

Phosphorus (mg/dL)

356,401

4.8 (1.2)

16,288

4.1 (1.0)

340,113

4.8 (1.2)

< 0.001

Parathyroid Hormone (pg/mL)

83,940

367 (314)

3755

221 (187)

80,185

374 (317)

< 0.001

Vascular Access Type

      

< 0.001

 AVF/AVG

87,996

24.3%

915

5.5%

87,081

25.2%

 

 Catheter

255,931

70.8%

14,817

89.4%

241,114

69.9%

 

 Other

17,819

4.9%

837

5.1%

16,982

4.9%

 

Treatment time per session (minutes)

335,737

223 (28)

15,996

219 (29)

319,741

223 (28)

< 0.001

Single pool Kt/V

353,328

1.5 (0.3)

16,101

1.5 (0.3)

337,227

1.5 (0.3)

< 0.001

Normalized protein catabolic rate (g/kg/d)

270,580

0.8 (0.2)

10,943

0.70 (0.2)

259,637

0.8 (0.2)

< 0.001

Pre-HD weight (kg)

335,856

84.3 (23.9)

16,004

85.8 (24.7)

319,852

84.2 (23.8)

< 0.001

Post-HD weight (kg)

335,855

82.3 (23.5)

16,004

84.2 (24.3)

319,851

82.2 (23.4)

< 0.001

Mean ultrafiltration rate (ml/kg/hr)

372,271

6.9 (3.1)

16,920

5.4 (3.5)

355,351

7.0 (3.1)

< 0.001

Quintile of ultrafiltration rate

      

< 0.001

 1st (lowest) (<=4.3)

74,454

20.0%

6779

40.1%

67,675

19.0%

 

 2nd (> 4.3–5.9)

74,454

20.0%

3369

19.9%

71,085

20.0%

 

 3rd (> 5.9–7.3)

74,455

20.0%

2558

15.1%

71,897

20.2%

 

 4th (> 7.3–9.1)

74,454

20.0%

2117

12.5%

72,337

20.4%

 

 5th (> 9.1)

74,454

20.0%

2097

12.4%%

72,357

20.4%

 
  1. ESA Erythropoiesis-stimulating agent (includes all forms of ESA but predominantly epoeitin alfa during study period), AVF Arteriovenous fistula, AVG Arteriovenous graft, HD Hemodialysis. Note: collection of parathyroid hormone data in CROWNWeb ceased in April 2014
  2. aLaboratory values are reported as the mean (SD) for continuous variables, and as a proportion for categorical variables. Data is aggregated for the first 3 months after dialysis initiation